IndraLab
Statements
Anthra[1,9-cd]pyrazol-6(2H)-one inhibits IFNB1. 3 / 3
|
3
reach
"However, the SP600125 treatment reversed this phenomenon of IFN-β at the late time point of CHv infection, indicating that inhibiting the activation of the JNK pathway will be beneficial to the regulation of the IFN signaling pathway under virus infection.Next, we explored the impact of the JNK pathway on viral replication."